---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-065810"
form_type: "8-K"
ticker: "OPRX"
cik: "0001448431"
company_name: "OptimizeRx Corp"
filed_at: "2026-06-05T20:10:29+00:00"
generated_at: "2026-06-05T20:21:00.042021+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# OptimizeRx CCO Theresa Greco to depart June 15; advisory role through June 2027

## Summary
- Greco's separation effective June 15, 2026; she will serve as advisor through June 15, 2027.
- She receives 12 months' base salary continuation at $380,000/yr, a $209,000 lump sum bonus target, and COBRA reimbursement for 12 months.
- Equity grants continue to vest during the 12-month advisory term; change-of-control special bonus preserved.
- Greco subject to 12-month non-compete and non-solicit obligations under Business Protection Agreement.

## SEC filing metadata
- accession: 0001213900-26-065810
- form_type: 8-K
- ticker: OPRX
- cik: 0001448431
- company_name: OptimizeRx Corp
- filed_at: 2026-06-05T20:10:29+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1448431/000121390026065810/0001213900-26-065810-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1448431/000121390026065810/ea0293598-8k_optimize.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-065810
- JSON: https://secwatch.observer/filing/0001213900-26-065810.json
- Plain text: https://secwatch.observer/filing/0001213900-26-065810.txt

## Key facts
- Executive change
  Theresa Greco departed as Chief Commercial Officer at OptimizeRx Corp.
  - Action: separated
  - Role: Chief Commercial Officer
  source text: Accordingly, effective as of the Separation Date, Ms. Greco will no longer serve as the Company’s Chief Commercial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1448431/000121390026065810/0001213900-26-065810-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.